Check-Cap Ltd. announced that preliminary data from pre-clinical and clinical studies of its ingestible capsule for preparation-free colorectal cancer screening were discussed during Digestive Disease Week (DDW) 2016, May 21-24 in San Diego.

Zebra Medical Vision announced an additional financing round of $12 million led by InterMountain Healthcare, with the participation of existing investors.

Cancer patients at the Carti Cancer Center, Little Rock, Ark., now have access to the latest innovation in diagnostic imaging with Toshiba America Medical Systems Inc.’s Infinix 4-D CT.

vRad (Virtual Radiologic) announced that it ranked No. 19 on 2016’s InformationWeek Elite 100, a list of top business-technology innovators in the United States.

New Mayo Clinic research suggests that many pancreatic cancer patients whose tumors have grown around the pancreas to encompass critical blood vessels are candidates for surgery, even though conventional wisdom has suggested otherwise.

Positron emission tomography (PET) is used commonly in the diagnosis of suspected lung cancer. Computed bioconductance (CB) id being investigated as a non-invasive way to predict whether an suspicious abnormality in the lung is benign or malignant. In a new study, researchers found that CB combined with PET before biopsy of suspicious lesions could improve diagnostic effectiveness of potentially cancerous lesions detected by computed tomography (CT) scan.

​​​​​​​In a new report, Ampronix looks at the rapid expansion of simulated procedures into medical education, including programs recently implemented for Baylor College and Tuoro University System.

Scientists are developing a new photonics device that listens to light and could be capable of detecting skin cancer and other diseases more accurately than ever before, eliminating the need for unnecessary and invasive biopsies.

No one really knows how epiphanies come to be. Those moments of enlightenment, slivers in time, when the curtains are thrown back and there, revealed, is the hardly expected.

Researchers at Haukeland University Hospital in Bergen, Norway, have combined a laboratory ultrasound technique with the commercially-available chemotherapy compound Gemcitabine to increase the porosity of pancreatic cells with microbubbles.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now